Author Affiliation: Department of Medicine, Beth Israel Deaconess Medical Center, Boston Massachusetts (email@example.com).
To the Editor: Three Commentaries1- 3 provided differing interpretations of the conclusion from the draft report of the US Preventive Services Task Force (USPSTF) that the harms of prostate-specific antigen (PSA) screening outweigh the benefits of treatment for PSA screen-detected prostate cancer and of the recommendation against the routine use of the test. Scientific evidence is lacking for their arguments for continuing the widespread use of PSA testing.
Garnick MB. Recommendations on Use of Prostate-Specific Antigen for Prostate Cancer Screening. JAMA. 2012;307(13):1372–1374. doi:10.1001/jama.2012.396
* * SCHEDULED MAINTENANCE * *
The JAMA Network Sites will be conducting routine maintenance from 10/20/2017 through 10/21/2017. During this window access to content and authentication may be intermittently available. The JAMA Store will be completely unavailable during the maintenance window.